TGFBR2 and Marfan syndrome: When TGFBR2 mutations reduce the receptor’s ability to activate Smad proteins, it results in insufficient signaling, leading to connective tissue defects and other symptoms typical of MFS and related disorders such as LDS (Horbelt et al., 2010).